Small-Molecule Drug Design and Discovery
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 1192
Special Issue Editor
Interests: drug design; small-molecule drugs; methodologies for synthetic drugs
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Small-molecule drug design involves creating novel chemical drugs that may achieve therapeutic effects based on the chemical structures of biological targets, utilizing the chemical structures, electrical charges, shapes, and other characteristics of organic small molecules. This process typically encompasses multiple steps, including target selection, molecular design, synthesis, and biological evaluation. The methods for small-molecule drug design are numerous, encompassing structure-based drug design, fragment-based drug discovery, and more contemporary advancements like PROTAC technology, molecular glue methodologies, and artificial intelligence technology. Through persistent exploration and groundbreaking innovations, we anticipate the emergence of numerous small-molecule drugs, thereby significantly enhancing our contributions to the advancement of human health.
Dr. Qiuqin He
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- small-molecule drug design
- structure-based drug design
- fragment-based drug discovery
- PROTAC technology
- artificial intelligence technology
- biological evaluation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
